Page 54 - Read Online
P. 54

Page 2 of 10                 Licordari et al. Vessel Plus 2022;6:12  https://dx.doi.org/10.20517/2574-1209.2021.86

               Results: A higher value of LV thickness, E/E’, and RRSR and lower LV volumes, EF, GLS, MBLS were observed in
               patients with CA than the ones with only TTRv. During follow-up (median of 7.7 years), 25 major events (23
               cardiac death and 2 appropriate ICD shocks) occurred. The logistic univariate analyses showed that LV EF, LV
               septal thickness, E/E’, GLS, and MBLS were all predictors of cardiovascular death. In multivariate analysis, MBLS
               was the only independent predictor of major events. A cut off of -14 of MBLS was selected as the best value to
               discriminate a worse prognosis on Kaplan-Meyer analysis.

               Conclusion: Longitudinal dysfunction is observed in the early stages of ATTRv amyloidosis with cardiomyopathy.
               Medio-basal LV longitudinal dysfunction is a strong independent echocardiographic predictor of cardiac death.

               Keywords: Cardiac amyloidosis, myocardial strain imaging, prognosis



               INTRODUCTION
               Familial transthyretin amyloidosis due to a mutation of the gene coding for transthyretin (TTRv) is one of
               the three most frequent subtypes, together with light chain (AL) and wild-type TTR amyloidosis
                       [1-3]
               (wtTTR) . Among these, mutated TTR represents the most uncommon form of cardiac amyloidosis (CA).

               In TTRv patients, penetrance and disease phenotype is variable according to the different well-known TTR
               gene mutations . In the clinical management of carriers, the identification of early cardiac involvement,
                            [4]
               ideally in a presymptomatic stage, is of paramount importance to achieve correct management and early
               treatment.


               Non-invasive diagnosis of CA is performed using an integrated evaluation of biomarkers (troponins and
               natriuretic peptides), echocardiography, cardiac magnetic resonance, and  Tc-3,3-diphosphono-1,2
                                                                                  99m
               propanodicarboxylic acid (DPD) scintigraphy. DPD scintigraphy, identifying with high accuracy TTR-
               related amyloidosis, is considered the non-invasive gold standard diagnostic tool for ATTR amyloidosis
               with cardiomyopathy .
                                 [5-7]

               In clinical practice, echocardiography is the imaging tool most used during both initial evaluation and
               follow-up of CA patients. A relative “apical sparing” pattern of longitudinal deformation is an easily
               recognizable, accurate, and reproducible method of differentiating CA from other causes of left ventricular
               (LV) hypertrophy .
                              [8]
               Echocardiographic parameters such as increased LV wall thickness, global longitudinal strain (GLS),
               reduced ejection fraction (EF), and a high relative regional strain ratio are independent predictors of cardiac
               mortality in AL amyloidosis .
                                       [9]
               On the contrary, no large studies have evaluated the prognostic role of an integrated echocardiographic
               approach in patients with ATTR amyloidosis with cardiomyopathy especially in the early stage of the
               disease.

               Our study aimed to assess the best conventional and strain-derived echocardiographic prognostic
               parameters in the early clinical stage of ATTRv amyloidosis with cardiomyopathy.
   49   50   51   52   53   54   55   56   57   58   59